Skip to search formSkip to main contentSkip to account menu

GR 138950

Known as: GR-138950, GR138950 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The actions of angiotensin II on type 1 (AT₁) and type 2 (AT₂) receptor subtypes are important for normal kidney development… 
2004
2004
Glucocorticoids increase blood pressure in utero, but the mechanisms responsible are unclear. This study investigated the… 
1999
1999
The purpose of this study was to determine whether Angiotensin II (Ang II) contributes to the regulation of resting hemodynamics… 
1998
1998
1 The cardiovascular profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential compensatory… 
1997
1997
1 The effect of systemic administration of the nitric oxide synthase inhibitor, NG‐nitro‐L‐arginine methyl ester (L‐NAME) on the… 
1997
1997
1. The antagonist activity of the angiotensin AT1 receptor antagonist, GR138950, and its haemodynamic effects have been… 
1996
1996
1 The effects of antagonism of the maternal renin‐angiotensin system (RAS) with either an angiotensin II type 1‐(AT1) specific… 
1996
1996
1 The angiotensin AT1 receptor antagonist, GR138950, produces a long‐lasting antihypertensive effect in conscious renal artery… 
1995
1995
The antagonist activity of GR138950 (1-[[3-bromo-2-[2-[[(trifluoromethyl)sulphonyl]amino]phenyl]-5- benzofuranyl]methyl]-4…